Nifty50: ETMarkets Investors’ Guide: Is it time to buy the dip once again? | The Economic Times Podcast

Amid worries related to the new variant of Covid-19 in South Africa, headline index Nifty50 is now down 9 per cent from its 52-week high. Nifty Pharma was the only sectoral index that ended in the green as India VIX shot up by as much as 40 per cent last week.

In today’s special podcast with independent market expert Rajiv Nagpal, lets understand how to navigate the ongoing volatility in the market.

Listen in.

Welcome to the show Mr Nagpal.

1) From a trader’s perspective, how serious do you think is the threat posed by the new Covid variant?

2) Is it a good time to buy the dip once again or should one sell on the rise?

3) Several pharma stocks that were not on the radar earlier are now finding favour. Should one go long on select pharma stocks for a few days?

4) Which pockets of the market are now looking attractive valuation-wise?

Thank you Mr Nagpal. That’s all in today’s special podcast. But do keep checking this space for more such interesting content. Good bye!